CCL21 and atherosclerosis: A study by Guedj et al31 confirmed that the inflammatory factor CCL21 (C–C motif chemokine ligand 21) in human abdominal aortic aneurysms can trigger smooth muscle cells to produce chemokines, thereby aiding in the recruitment of immune cells and development of atherosclerosis.